Dr. Krall is Adjunct Professor of Neurology at the University of Rochester and Adjunct Associate Professor of Neurology and Member of the Center for Bioethics and Health Law at the University of Pittsburgh. He is Chairman of the Board of the Board of Pierian Biosciences, an Advisor at Propel Bio Partners Equity Investment Firm, and an independent member of the Safety Board of Takeda Pharmaceuticals.
Former Chief Medical Officer for GlaxoSmithKline (Retired), Dr. Krall worked for four companies (Lorex Pharmaceuticals, Abbott Laboratories, Zeneca/AstraZeneca and GlaxoSmithKline) over 25 years, during which time he oversaw the approval of more than 20 medicines. His areas of expertise include the ethics of human subject experimentation, drug development, regulatory science and the safety of medicines. Dr. Krall was a founding member of the Observational Medical Outcomes Partnership, served on its Executive Committee and led its research subcommittee.
Dr. Krall is a graduate of Phillips Exeter Academy, holds a B.A. in mathematics from Swarthmore College, an M.D. from the University of Pittsburgh, was a Staff Associate in the Epilepsy Branch of the National Institutes of Health, and completed his training in neurology and a fellowship in Clinical Pharmacology at the University of Rochester.
Dr. Krall currently makes his home in Steamboat Springs, Colorado, where he serves as advisor and ranch manager for BookTrails, a 501(c)3 literacy organization for children, and owns with his wife Off the Beaten Path, an independent bookstore, coffeehouse and bakery café (www.steamboatbooks.com) – one of the 28 “coolest” independent bookstores in America (https://matadornetwork.com/read/28-coolest-independent-book- stores-us/).
Current role